139 results about "Respiratory flow" patented technology

CPAP treatment apparatus is disclosed having a controllable flow generator (34, 38, 40) operable to produce breathable gas at a treatment pressure elevated above atmosphere to a patient by a delivery tube (32) coupled to a mask (30) having connection with a patient's airway. A sensor (44, 50, 56, 58) generates a signal representative of patient respiratory flow, that is provided to a controller (54, 62, 64). The controller (54, 62, 64) is operable to determine the occurrence of an apnea from a reduction in respiratory airflow below a threshold, and if an apnea has occurred, to determine the duration of the apnea and to cause the flow generator (34, 38) to increase the treatment pressure. In one preferred form the increase in pressure is zero if the treatment pressure before the apnea exceeds a pressure threshold. Below the pressure threshold the increase in pressure is an increasing function of the duration of the apnea multiplied by the difference between the pressure threshold and the current treatment pressure.

A method of operating a CPAP apparatus in which the interface pressure is controlled to rapidly drop at the start of expiration by an expiratory relief pressure (ERP) that is independent of instantaneous respiratory flow, following which the pressure rises to an inspiratory level at or shortly before the end of expiration, or at the onset of an expiratory pause, if any. The ERP is an increasing function of the inspiratory pressure. The expiratory pressure follows a template that is a function of the expected expiration time, the magnitude of the template being equal to the ERP. The current estimated proportion of expiration is determined by comparing the expiration time of the breath in progress to low-pass filtered expiratory durations measured for a number of the preceding breaths.

An apnea / hypopnea detection system and method that monitors a patient's respiratory flow, determines (a) a long term RMS energy based on the flow, (b) a long term threshold determined based on the long term RMS energy, and (c) a short term RMS energy based on the flow. Determining whether the patient is experiencing an apnea / hypopnea is accomplished by comparing the short term RMS energy with the long term threshold. This A / H detection technique is useful in diagnosing a patient for a breathing disorder, such as OSA, and / or for controlling an auto-titration pressure support system.

A device for the controlled inhalation of therapeutic aerosols comprises means providing individual patient parameters and / or aerosol parameters for the inhalation. The aerosol doses, such as the tidal volume and the respiratory flow, are individually adjusted on the basis of these individual parameters. Thus, the inhalation device may be individually adjusted to the patient to be treated.

The method and system are for sealing / unsealing (regulating) airway leaks occurring between the ventilator circuit and respiratory airways during lung ventilatory support in response to myoelectrical activity of diaphragm. Myolectrical activity of a patient's respiratory-related muscle is sensed to detect respiratory effort, and to produce a myoelectrical signal representative of the sensed muscle myoelectrical activity. Respiratory flow and pressure can also be measured to produce respective respiratory pressure and respiratory flow signals. A logic trigger sealing / unsealing of airway leaks in relation to the myoelectrical signal, respiratory flow signal and / or respiratory pressure signal to assist respiration of the patient. The amplitude of the myoelectrical signal is compared to a given threshold, and airway leaks are sealed when the amplitude of the myoelectrical signal is higher than this threshold. Increment of myoelectrical signal amplitude can be also detected to trigger the airway leak regulating device to seal the airway leaks, while decrement of the myoelectrical signal amplitude can be detected to unseal the airway leaks and thus permit air evacuation from the patient's lungs.

The invention features methods and apparatus for the treatment of asthma patients. A controlled supply of breathable air delivered to a patient interface or mask (4) is controlled for patient comfort to maintain a steady pressure level in a range 2 to 4 cm H2O to accommodate patient respiration. The breathable air is cleaned by a high efficiency particulate arresting filter (10) to remove allergens from the air supply. The apparatus may be programmed to automatically detect asthma-related symptoms such as an asthma attack by analyzing the respiratory flow of the patient. In response to the detection of such an attack, the apparatus may provide an audible warning or if configured with a treatment delivery module (14A, 14B), the device may administer a therapeutically effective dose of a drug or substance, for example, a broncho-dilator, to alleviate the patient's breathing difficulty. Preferred mask designs allow for proper CO2 washout to accommodate the low pressures supplied to the mask and prevent asphyxia.

An oral-nasal cannula comprising at least one nasal breath inlet for carbon dioxide (CO2) sampling; and at least one nasal breath inlet for flow measurement, wherein said at least one nasal breath inlet for flow measurement is separated from said at least one nasal breath inlet for CO2 sampling, such that said cannula is configured to facilitate CO2 sampling and flow measurement essentially without cross-interference.

The invention resides in a respiratory sonification monitoring method and system for monitoring respiration in a subject including the use of capnometric means for measuring carbon dioxide concentrations, flowmeter means for measuring gas flow and volume of gas; means adapted to process into digital information, signal output from the capnometric means and the flowmeter means, sound synthesizer means adapted to convert the digital information into synthesised audio output, wherein, changes in respiratory flow during inhalation and exhalation, and changes in end tidal carbon dioxide concentrations (ETC02) and cumulative tidal volume (cumVt) of the subject can be represented as changes in synthesised sound heard through a loudspeaker, headphone or ear piece.

A respiratory tract differential-pressure flow sensor, including a tube having a distal end that is insertable into a respiratory tract, an interfering body disposed within the tube proximal to the distal end and having a first edge facing one end of the tube and a second edge facing away from the end, the interfering body extending across the diameter of the tube, a first pressure sensing port operative to sense an air pressure, the first port being disposed in the first edge not abutting the wall of the tube, and a second pressure sensing port operative to sense an air pressure, the second port being disposed in the second edge not abutting the wall of the tube, where either of the edges is inclined inwardly towards the axis of the interfering body extending across the diameter of the tube.

A system (300) for measuring a metabolic parameter. The system includes an integrated airway adapter (20, 100, 200) capable of monitoring any combination of respiratory flow, O2 concentration, and concentrations of one or more of CO2, N2O, and an anesthetic agent in real time, breath by breath. Respiratory flow may be monitored with differential pressure flow meters under diverse inlet conditions through improved sensor configurations which minimize phase lag and dead space within the airway. Molecular oxygen concentration may be monitored by way of luminescence quenching techniques. Infrared absorption techniques may be used to monitor one or more of CO2, N2O, and anesthetic agents.

A method and system for detecting an ineffective effort of a patient being mechanically ventilated by a ventilator comprises (i) monitoring a respiratory flow of air of the patient after said ventilator has cycled; (ii) creating a signal indicative of said flow; (iii) removing artefact from said signal; (iv) monitoring said signal for perturbations; and (v) determining that an ineffective effort has occurred when said perturbation is significant.

A controller or processor for a respiratory pressure treatment device determines an estimate of patient respiratory flow based on a measure of pressure associated with flow generated by a flow generator and a measure of frequency of the flow generator, such as a rotational velocity of a servo-controlled blower motor. The estimate can be made without data from a flow sensor. The measure of frequency may be converted to an expected pressure based on characteristics of the flow generator and subtracted from the measured pressure to determine the flow estimate. The flow estimate can be implemented in the provision of respiratory pressure treatment with the flow generator. For example, the flow estimate may be utilized to trigger expiratory pressure relief during a patient's expiration as detected with the estimated flow signal.

In a CPAP or positive pressure ventilation system, leak is determined at each instant by a lookback for a time as long as single breath to establish the start of an averaging window over which low-pass filtered values used in the determination of a parameter of a leak model are averaged. A jamming index indicates whether the leak is rapidly changing. To the extent that jamming is high, the leak estimate used progressively changes from that using sliding breath-window averaging to a more robust and faster responding low-pass filter method, and adjustment of ventilatory support based on measures employing estimated respiratory flow is slowed down or stopped.